Susan M. Molineaux,Matthew I. Gross,Susan D. Bromley,Francesco Parlati,Mark K. Bennett
申请号：
US16265529
公开号：
US20190231776A1
申请日:
2019.02.01
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The invention relates to methods of treating cancer, myeloproliferative diseases, or immunological or neurological diseases with a combination of a glutaminase inhibitor and an immuno-oncology therapeutic agent, such as an inhibitor of arginase, CTLA-4, indoleamine 2,3-dioxygenase, and/or PD-1/PD-L1.
